ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $294 | -29.5% | 300 | 0.0% | 0.00% | – |
| Q2 2023 | $417 | -12.6% | 300 | 0.0% | 0.00% | – |
| Q1 2023 | $477 | -74.5% | 300 | 0.0% | 0.00% | – |
| Q4 2022 | $1,869 | -6.6% | 300 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -66.7% | 300 | 0.0% | 0.00% | – |
| Q2 2021 | $6,000 | -25.0% | 300 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $8,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $8,000 | -27.3% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $11,000 | -26.7% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $15,000 | +66.7% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $9,000 | -50.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $18,000 | +63.6% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $11,000 | -21.4% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $14,000 | +16.7% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $12,000 | -14.3% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $14,000 | +7.7% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $13,000 | +8.3% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $12,000 | -45.5% | 300 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $22,000 | +10.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $20,000 | +33.3% | 300 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $15,000 | +7.1% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $14,000 | +27.3% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $11,000 | +175.0% | 300 | 0.0% | 0.00% | – |
| Q4 2016 | $4,000 | 0.0% | 300 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $4,000 | +33.3% | 300 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | -40.0% | 300 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $5,000 | -28.6% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $7,000 | +75.0% | 300 | +100.0% | 0.00% | 0.0% |
| Q3 2015 | $4,000 | -50.0% | 150 | +50.0% | 0.00% | 0.0% |
| Q2 2015 | $8,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |